Noradrenergic β-receptor antagonism within the central nucleus of the amygdala or bed nucleus of the stria terminalis attenuates the negative/anxiogenic effects of cocaine

Journal of Neuroscience

Volumn 34, Issue 10, 2014, Pages 3467-3474

  Wenzel, Jennifer M ^a   Cotten, Samuel W ^a   Dominguez, Hiram M ^a   Lane, Jennifer E ^a   Shelton, Kerisa ^a   Su, Zu In ^a   Ettenberg, Aaron ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETAXOLOL; COCAINE; NORADRENALIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONFLICT; CONTROLLED STUDY; DRUG MEGADOSE; HISTOLOGY; LATENT PERIOD; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; STRESS; STRIA TERMINALIS;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; AMYGDALA; ANIMALS; ANXIETY; COCAINE; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SEPTAL NUCLEI;

EID: 84895460022     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3861-13.2014     Document Type: Article

References (55)

1. Anthony J. C, Tien AY, Petronis KR (1989) Epidemiologic evidence on cocaine use and panic attacks. Am J Epidemiol 129:543-549. Medline
2. Aston-Jones G, Chiang C, Alexinsky T (1991) Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog Brain Res 88;501-520. CrossRef Medline
3. Aston-Jones G, Delfs JM, Druhan J, Zhu Y (1999) The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci 877;486-98. CrossRef Medline
4. Blanchard D. C, Blanchard RJ (1999) Cocaine potentiates defensive behaviors related to fear and anxiety. Neurosci Biobehav Rev 23:981-991. CrossRef Medline
5. Carelli R. M (2002) The nucleus accumbens and reward: neurophysiological investigations in behaving animals. Behav Cogn Neurosci Rev 1:281-296. CrossRef Medline
6. Carr G. D, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: The neuropharmacological basis of reward (Liebman, JM and Cooper SJ, eds), pp 264-319. New York: Clarendon/ Oxford UP.
7. Cecchi M., Khoshbouei H, Javors M, Morilak DA (2002) a) Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 112:13-21. CrossRef Medline
8. Cecchi M., Khoshbouei H, Morilak DA (2002) b) Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology 43:1139-1147. CrossRef Medline
9. Cohen A., Young RW, Velazquez MA, Groysman M, Noorbehesht K, Ben-Shahar O. M, Ettenberg A (2009) Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflict. Psychopharmacology 204: 541-549. CrossRef Medline
10. DavisM (2006) Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 61:741-756. CrossRef Medline
11. Deadwyler S. A (2010) Electrophysiological correlates of abused drugs: relation to natural rewards. Ann N Y Acad Sci 1187;140-47. CrossRef Medline
12. Ettenberg A. (2004) Opponent process properties of self-administered cocaine. Neurosci Biobehav Rev 27:721-728. CrossRef Medline
13. Ettenberg A. (2009) The runway model of drug self-administration. Pharmacol Biochem Behav 91:271-277. CrossRef Medline
14. Ettenberg A., Bernardi RE (2006) Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration. Pharmacol Biochem Behav 85:393-399. CrossRef Medline
15. Ettenberg A., Bernardi RE (2007) Effects of buspirone on the immediate positive and delayed negative properties of intravenous cocaine as measured in the conditioned place preference test. Pharmacol Biochem Behav 87;171-8. CrossRef Medline
16. Ettenberg A., Geist TD (1991) Animal model for investigating the anx-iogenic effects of self-administered cocaine. Psychopharmacology 103: 455-461. CrossRef Medline
17. Ettenberg A., Geist TD (1993) Qualitative and quantitative differences in the operant runway behavior of rats working for cocaine and heroin reinforcement. Pharmacol Biochem Behav 44:191-198. CrossRef Medline
18. Ettenberg A., Raven MA, Danluck DA, Necessary BD (1999) Evidence for opponent-process actions of intravenous cocaine. Pharmacol Biochem Behav 64;507-12. CrossRef Medline
19. Galvez R., Mesches MH, McGaugh JL (1996) Norepinephrine release in the amygdala in response to footshock stimulation. Neurobiol Learn Mem 66:253-257. CrossRef Medline
20. Gardner E. L (2011) Addiction and brain reward and antireward pathways. Adv Psychosom Med 30;22-60. CrossRef Medline
21. Geist T. D, Ettenberg A (1990) A simple method for studying intravenous drug reinforcement in a runaway. Pharmacol Biochem Behav 36:703-706. CrossRef Medline
22. Geist T. D, Ettenberg A (1997) Concurrent positive and negative goalbox events produce runway behaviors comparable to those of cocaine-reinforced rats. Pharmacol Biochem Behav 57:145-150. CrossRef Medline
23. Gil M., Marti J, Armario A (1992) Inhibition of catecholamine synthesis depresses behavior of rats in the holeboard and forced swim tests: influence of previous chronic stress. Pharmacology, biochemistry and behavior 43:597-601. CrossRef Medline
24. Gracy K. N, Dankiewicz LA, Koob GF (2001) Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24:152-160. CrossRef Medline
25. Guzman D., Ettenberg A (2004) Heroin attenuates the negative consequences of cocaine in a runway model of self-administration. Pharmacol Biochem Behav 79:317-324. CrossRef Medline
26. Hamlin A. S, Buller KM, Day TA, Osborne PB (2004) Effect of naloxoneprecipitatedmorphinewithdrawalonc-fosexpressioninratcorticotropinreleasing hormone neurons in the paraventricular hypothalamus and extended amygdala. Neurosci Lett 362:39-43. CrossRef Medline
27. Itoi K., SugimotoN (2010) The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol 22:355-361. CrossRef Medline
28. Kilts C. D, Anderson CM (1986) The simultaneous quantification of dopamine, norepinephrine and epinephrine in micropunched rat brain nuclei by on-line trace enrichment HPLC with electrochemical detection: Distribution of catecholamines in the limbic system. Neurochem Int 9:437-445. CrossRef Medline
29. Knackstedt L. A, Samimi MM, Ettenberg A (2002) Evidence for opponentprocess actions of intravenous cocaine and cocaethylene. Pharmacol Biochem Behav 72:931-936. CrossRef Medline
30. Koob G. F, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52-58. CrossRef Medline
31. Leri F., Flores J, Rodaros D, Stewart J (2002) Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22:5713-5718. Medline
32. Miller N. E (1944) Experimental studies of conflict. In: Personality and behavior disorders (Hunt I McV, ed), pp 431-465. New York: Ronald.
33. Moore R. Y, Bloom FE (1979) Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 2:113-168. CrossRef Medline
34. Nakagawa T., Yamamoto R, Fujio M, Suzuki Y, Minami M, Satoh M, Kaneko S (2005) Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 134:9-19. CrossRef Medline
35. Otis J. M, Mueller D (2011) Inhibition of β-adrenergic receptors induces a persistent deficit in retrieval of a cocaine-associated memory providing protection against reinstatement. Neuropsychopharmacology 36:1912-1920. CrossRef Medline
36. Pacak K., McCarty R, Palkovits M, Kopin IJ, Goldstein DS (1995) Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats. Brain Res 688 (1-2);242-6.
37. Paxinos G., Watson C (2005) The rat brain in stereotaxic coordinates. New York: Elsevier Academic.
38. Phelix C. F, Liposits Z, Paull WK (1992) Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation. Brain Res Bull 28:949-965. CrossRef Medline
39. Raven M. A, Necessary BD, Danluck DA, Ettenberg A (2000) Comparison of the reinforcing and anxiogenic effects of intravenous cocaine and cocaethylene. Exp Clin Psychopharmacol 8:117-124. CrossRef Medline
40. Rogerio R., Takahashi RN (1992) Anxiogenic properties of cocaine in the rat evaluated with the elevated plus maze. Pharmacol Biochem Behav 43: 631-633. CrossRef Medline
41. Rudoy C. A, Van Bockstaele EJ (2007) Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog Neuropsychopharmacol Biol Psychiatry 31:1119-1129. CrossRef Medline
42. Rudoy C. A, Reyes AR, Van Bockstaele EJ (2009) Evidence for beta1-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal. Neuropsychopharmacology 34:1135-1148. CrossRef Medline
43. Schank J. R, Liles LC, Weinshenker D (2008) Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaineinduced anxiety. Biol Psychiatry 63:1007-1012. CrossRef Medline
44. Schweimer J., Fendt M, Schnitzler HU (2005) Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats. Eur J Pharmacol 507;117-124. CrossRef Medline
45. Shaham Y., Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168(1-2);3-20.
46. Smith R. J, Aston Jones G (2008) Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 213(1-2);43-61.
47. Stone E. A, Manavalan SJ, Zhang Y, Quartermain D (1995) Beta adrenoceptor blockade mimics effects of stress on motor activity in mice. Neuropsychopharmacology 12:65-71. Medline
48. Su Z., Wenzel J, Ettenberg A, Ben-Shahar O (2013) Prior extended daily access to cocaine elevates the reward threshold in a conditioned place preference test. Addict Biol, in press.
49. van Stegeren AH (2008) The role of the noradrenergic system in emotional memory. Acta Psychol (Amst) 127:532-541. CrossRef Medline
50. Watanabe T., Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M (2003) Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology 170:80-88. CrossRef Medline
51. Wenzel J. M, Waldroup SA, Haber ZM, Su ZI, Ben-Shahar O, Ettenberg A (2011) Effects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in rats. Psychopharmacology 217:221-230. CrossRef Medline
52. Williamson S., Gossop M, Powis B, Griffiths P, Fountain J, Strang J (1997) Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend 44:87-94. CrossRef Medline
53. Willuhn I., Wanat MJ, Clark JJ, Phillips PE (2010) Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci 3;29-71. CrossRef Medline
54. Wise R. A (1984) Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr 50;15-33. Medline
55. Wise R. A, BozarthMA (1985) Brain mechanisms of drug reward and euphoria. Psychiatr Med 3:445-460. Medline